To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3479 | Mrl-770 |
Novel selective and reproducible inhibitor of DNA synthesis in E. coli JL553
More description
|
|
| DCC3478 | Mrl-367 |
Novel potent and selective RORγT inhibitor, showing no appreciable activity against a panel of related nuclear hormone receptors
More description
|
|
| DCC3477 | Mrl-299 |
Novel potent RORγT inhibitor
More description
|
|
| DCC3476 | Mrl-248 |
Novel potent and selective RORγT inhibitor, showing no appreciable activity against a panel of related nuclear hormone receptors
More description
|
|
| DCC3475 | Mri-1891 |
Novel peripheral CB1R antagonist, being highly biased toward inhibiting CB1R-induced β-arrestin-2 (βArr2) recruitment over G-protein activation
More description
|
|
| DCC3474 | Mrgx1-activator-1 |
Activator of MrgX1 receptor signaling
More description
|
|
| DCC3473 | Mrgprx1 Pam 1t |
Novel positive allosteric modulator (PAM) of mas-related G protein-coupled receptor X1 (MRGPRX1), reducing behavioral heat hypersensitivity in humanized MRGPRX1 mice, demonstrating the therapeutic potential in treating neuropathic pain
More description
|
|
| DCC3472 | Mr6-31-2 |
Novel inhibitor of the main protease (Mpro) of SARS-CoV-2
More description
|
|
| DCC3471 | Mr22388 |
Novel, potent inducer of apoptosis via the MAP kinase pathways. Inhibitor of several kinases including the tyrosine kinase FLT3-ITD
More description
|
|
| DCC3470 | Mq02-439 |
Novel highly potent and selective 5-HT2C agonist
More description
|
|
| DCC3469 | Mpx-007 |
Novel potent and selective antagonist of GluN2A-containing NMDA receptors
More description
|
|
| DCC3468 | Mptp-in-22 |
Novel mitochondrial permeability transition pore (mPTP) inhibitor
More description
|
|
| DCC3467 | Mpt0b451 |
Novel Dual HDAC6 and Tubulin Inhibitor, Displaying Anti-tumor Ability in Human Cancer Cells
More description
|
|
| DCC3466 | Mpt0b206 |
Novel tubulin polymerization inhibitor
More description
|
|
| DCC3465 | Mps-bay2b |
Novel inhibitor of MPS1
More description
|
|
| DCC3464 | mps1 Inhibitor I |
Novel Mps1 Kinase Inhibitor
More description
|
|
| DCC3463 | Mpro-in-n3 |
Novel main protease (Mpro) inhibitor, inhibiting MHV-A29, HCoV-229E, FOPV replication, and SARS-CoV-2 viral cell entry
More description
|
|
| DCC3462 | Mpp Dihydrochloride |
Specific estrogen receptor α (ERα) antagonist
More description
|
|
| DCC3461 | Mpo-0029 |
Potent and selective COX-2 inhibitor
More description
|
|
| DCC3460 | Mpk576 |
Novel selective class IIb histone deacetylase inhibitor (HDACi), dose-dependently decreasing the viability of Acanthamoeba trophozoites
More description
|
|
| DCC3459 | mpi621 |
Novel anti-cancer agent, being more potent and safer than conventional indomethacin
More description
|
|
| DCC3458 | Mpges-1 Inhibitor-2 |
Novel potent and selective microsomal prostaglandin E synthase-1 (mPGES-1) inhibitor
More description
|
|
| DCC3457 | Mp1104 |
Novel mixed kappa-delta opioid receptor agonist with anti-cocaine properties and reduced side-effects in rats
More description
|
|
| DCC3456 | Mp-10 Succinate |
Potent and Specific PDE10A inhibitor
More description
|
|
| DCC3455 | Naucledine |
Natural antibacterial, antileishmanial, and antifungal agent
More description
|
|
| DCC3454 | Mosapramine Dihydrochloride |
Potent dopamine antagonist with high affinity to the D2, D3, and D4 receptors, and with moderate affinity for the 5-HT2 receptors
More description
|
|
| DCC3453 | Morellic Acid |
Natural analogue of (-)-gambogic acid acting as a potent inhibitor of global predominant MRSA USA300
More description
|
|
| DCC3452 | Moracin T |
Natural potent antioxidant agent
More description
|
|
| DCC3451 | Mon-dnj |
Novel iminosugar, downregulatiing the interferon γ receptor by dengue virus
More description
|
|
| DCC3450 | Momordicoside L |
Natural antioxidant and antidiabetic agent
More description
|
|